Information regarding discounts for Levalbuterol Tartrate is not directly available from the provided context. However, understanding drug pricing often involves factors like patent exclusivity and potential for generic competition.
When does Levalbuterol Tartrate patent protection expire?
Information on the specific patent expiry dates for Levalbuterol Tartrate is not provided. However, patent expiry is a critical factor that can influence drug pricing and the availability of lower-cost alternatives. DrugPatentWatch.com tracks patent information for many medications [1].
Can generic versions of Levalbuterol Tartrate be produced?
The ability to produce generic versions of Levalbuterol Tartrate is directly tied to patent expiry and regulatory approval. Once patents expire, and if bioequivalence is demonstrated, generic manufacturers can seek FDA approval to market their versions, which typically leads to lower prices [1].
How does Levalbuterol Tartrate work?
Levalbuterol tartrate is a bronchodilator used to treat or prevent bronchospasm in people with reversible obstructive airway disease. It works by relaxing muscles in the airways, making it easier to breathe [2].
What conditions is Levalbuterol Tartrate prescribed for?
Levalbuterol tartrate is indicated for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease [2].
What are the potential side effects of Levalbuterol Tartrate?
Common side effects of Levalbuterol Tartrate can include headache, dizziness, nervousness, shakiness, throat irritation, and flu-like symptoms. More serious side effects, though less common, may involve chest pain, rapid or pounding heartbeat, and changes in blood pressure [2].
How is Levalbuterol Tartrate administered?
Levalbuterol tartrate is typically administered via a nebulizer [2].
What is the difference between Levalbuterol and Albuterol?
Levalbuterol is the R-isomer of albuterol. While both are bronchodilators, levalbuterol is designed to target specific receptors in the lungs, potentially offering a more targeted effect with fewer side effects compared to racemic albuterol, which contains both R and S isomers [3].
Who manufactures Levalbuterol Tartrate?
Specific manufacturers of Levalbuterol Tartrate are not detailed in the provided context.
Sources:
[1] DrugPatentWatch.com
[2] Levalbuterol Tartrate Package Insert
[3] Physician's Desk Reference